Lactiplantibacillus plantarum DT88
Lactiplantibacillus plantarum DT88 was one of the strains tested in a 2025 mouse study of microplastic exposure. This is preclinical animal research that has not been repeated in people, and no human clinical data are available for this strain. L. plantarum as a species has a broad scientific literature covering gut barrier function, immune modulation, and fermentation applications, though findings at the species level cannot be assumed to apply to DT88 specifically without further strain-level investigation. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 2 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
2 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 39867494 →Novel probiotics adsorbing and excreting microplastics in vivo show potential gut health benefits· Frontiers in Microbiology · 2025